Report overview
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
This report aims to provide a comprehensive presentation of the global market for Radiopharmaceuticals for Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceuticals for Therapeutic. This report contains market size and forecasts of Radiopharmaceuticals for Therapeutic in global, including the following market information:
Global Radiopharmaceuticals for Therapeutic Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Radiopharmaceuticals for Therapeutic market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Radium-223 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Radiopharmaceuticals for Therapeutic include Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Lantheus and Spectrum Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Radiopharmaceuticals for Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Radiopharmaceuticals for Therapeutic Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Radiopharmaceuticals for Therapeutic Market Segment Percentages, by Type, 2022 (%)
Radium-223
Lutetium-177
Iodine-131
Other
Global Radiopharmaceuticals for Therapeutic Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Radiopharmaceuticals for Therapeutic Market Segment Percentages, by Application, 2022 (%)
Thyroid
Bone Metastasis
Lymphoma
Other
Global Radiopharmaceuticals for Therapeutic Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Radiopharmaceuticals for Therapeutic Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Radiopharmaceuticals for Therapeutic revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Radiopharmaceuticals for Therapeutic revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes
Outline of Major Chapters:
Chapter 1: Introduces the definition of Radiopharmaceuticals for Therapeutic, market overview.
Chapter 2: Global Radiopharmaceuticals for Therapeutic market size in revenue.
Chapter 3: Detailed analysis of Radiopharmaceuticals for Therapeutic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Radiopharmaceuticals for Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
